LOADING
Comparing UnitedHealth Group (UNH) and Johnson & Johnson (JNJ), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | UNH | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $350.2B | $651.3B |
| P/E Ratio | 25.1 | 31.4 |
| Forward P/E | 19.7 | 23.2 |
| PEG Ratio | 1.20 | 4.73 |
| EPS | $15.57 | $8.62 |
| Revenue Growth (YoY) | 0.4% | 6.6% |
| Profit Margin | 3.1% | 21.5% |
| Return on Equity | 14.1% | 25.7% |
| Dividend Yield | 2.33% | 1.96% |
| Beta | 0.63 | 0.23 |
| 52-Week High | $461.62 | $276.47 |
| 52-Week Low | $254.52 | $170.33 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. UnitedHealth Group trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. UnitedHealth Group offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.